231 related articles for article (PubMed ID: 32683563)
21. [Clinical study on the effects of neoadjuvant chemotherapy on lymph node ratio, prognosis, and survival analysis of stage ⅢA-N2 non-small cell lung cancer].
Wei YL; Cui YH; Dong YH; Shi WJ
Zhonghua Yi Xue Za Zhi; 2021 Jan; 101(4):259-264. PubMed ID: 33486934
[No Abstract] [Full Text] [Related]
22. The prognostic value of lymph node ratio in survival of non-metastatic breast carcinoma patients.
Singh D; Mandal A
Breast Cancer Res Treat; 2020 Dec; 184(3):839-848. PubMed ID: 32852709
[TBL] [Abstract][Full Text] [Related]
23. Lymph node ratio may predict the benefit of postoperative radiotherapy in non-small-cell lung cancer.
Urban D; Bar J; Solomon B; Ball D
J Thorac Oncol; 2013 Jul; 8(7):940-6. PubMed ID: 23695418
[TBL] [Abstract][Full Text] [Related]
24. Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer.
Taylor MD; LaPar DJ; Thomas CJ; Persinger M; Stelow EB; Kozower BD; Lau CL; Jones DR
Ann Thorac Surg; 2013 Oct; 96(4):1163-1170. PubMed ID: 23998409
[TBL] [Abstract][Full Text] [Related]
25. Comparison of 4 lymph node staging systems for the prognostic prediction of esophagogastric junction adenocarcinoma with ≤15 retrieved lymph nodes.
Yang Y; Zheng J; Li Y
Eur J Surg Oncol; 2022 May; 48(5):1017-1024. PubMed ID: 34876328
[TBL] [Abstract][Full Text] [Related]
26. Choice of postoperative radiation for stage IIIA pathologic N2 non-small cell lung cancer: impact of metastatic lymph node number.
Wang S; Ma Z; Yang X; Wang Y; Xu Y; Xia W; Chen R; Qiu M; Jiang F; Yin R; Xu L; Xu K
Radiat Oncol; 2017 Dec; 12(1):207. PubMed ID: 29284511
[TBL] [Abstract][Full Text] [Related]
27. Comparative analysis of methodologies for predicting overall survival in patients with non-small cell lung cancer based on the number and rate of resected positive lymph nodes: A study based on the SEER database for 2010 through 2019.
Guo Q; Hu S; Wang S; Su L; Zhang W; Xu J; Wei Y
Clin Respir J; 2023 Nov; 17(11):1145-1157. PubMed ID: 37723579
[TBL] [Abstract][Full Text] [Related]
28. Do tumours located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumours in other lobes?
Kudo Y; Saji H; Shimada Y; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
Eur J Cardiothorac Surg; 2012 Sep; 42(3):414-9. PubMed ID: 22398463
[TBL] [Abstract][Full Text] [Related]
29. Number of lymph nodes and metastatic lymph node ratio are associated with survival in lung cancer.
Nwogu CE; Groman A; Fahey D; Yendamuri S; Dexter E; Demmy TL; Miller A; Reid M
Ann Thorac Surg; 2012 May; 93(5):1614-9; discussion 1619-20. PubMed ID: 22440365
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of lymph node ratio in stage III non-small-cell lung cancer: A retrospective cohort study.
Zhang X; Feng N; Wu B; Wei Y; Zhang W
Medicine (Baltimore); 2023 Oct; 102(40):e35341. PubMed ID: 37800757
[TBL] [Abstract][Full Text] [Related]
31. Surgical choice for patients with stage I non-small-cell lung cancer ≤2 cm: an analysis from surveillance, epidemiology, and end results database.
Wu L; Zhao W; Chen T; Yang Y
J Cardiothorac Surg; 2021 Jul; 16(1):191. PubMed ID: 34233699
[TBL] [Abstract][Full Text] [Related]
32. [Postoperative survival analysis of patients with stage Ⅲ-pN2 non-small cell lung cancer].
Wu XW; Chen T; Yin S; Deng Y; Zhao B
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):782-786. PubMed ID: 30392344
[No Abstract] [Full Text] [Related]
33. Clinicopathological characteristics and lymph node metastasis pathway of non-small-cell lung cancer located in the left lingular division.
Shien K; Toyooka S; Soh J; Okami J; Higashiyama M; Kadota Y; Maeda H; Hayama M; Chida M; Funaki S; Okumura M; Miyoshi S
Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):791-6. PubMed ID: 25805399
[TBL] [Abstract][Full Text] [Related]
34. [Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases].
Zhang GQ; Han F; Gao SL; A DL; Pang ZL
Ai Zheng; 2007 May; 26(5):519-23. PubMed ID: 17672944
[TBL] [Abstract][Full Text] [Related]
35. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
[TBL] [Abstract][Full Text] [Related]
36. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer.
Gajra A; Newman N; Gamble GP; Kohman LJ; Graziano SL
J Clin Oncol; 2003 Mar; 21(6):1029-34. PubMed ID: 12637467
[TBL] [Abstract][Full Text] [Related]
37. A hypothesized TNM staging system based on the number and location of positive lymph nodes may better reflect the prognosis for patients with NSCLC.
Shang X; Liu J; Li Z; Lin J; Wang H
BMC Cancer; 2019 Jun; 19(1):591. PubMed ID: 31208403
[TBL] [Abstract][Full Text] [Related]
38. Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resection.
Yendamuri S; Dhillon SS; Groman A; Dy G; Dexter E; Picone A; Nwogu C; Demmy T; Hennon M
J Thorac Cardiovasc Surg; 2018 Jul; 156(1):394-402. PubMed ID: 29709364
[TBL] [Abstract][Full Text] [Related]
39. Negative Lymph Node Count and Lymph Node Ratio Are Associated With Survival in Male Breast Cancer.
Abd-Elhay FA; Elhusseiny KM; Kamel MG; Low SK; Sang TK; Mehyar GM; Nhat Minh LH; Hashan MR; Huy NT
Clin Breast Cancer; 2018 Dec; 18(6):e1293-e1310. PubMed ID: 30093263
[TBL] [Abstract][Full Text] [Related]
40. Negative Lymph Node Is an Independent Prognostic Factor for Stage III Gastric Cancer Patients After Curative Gastrectomy: A Surveillance, Epidemiology, and End Results-Based Study.
Liu L; Ren J; Wang G; Cui Y; Li F; Wang D; Lei X
Am Surg; 2023 Nov; 89(11):4413-4423. PubMed ID: 35861326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
